8.8 million euros for accelerated drug repurposing for rare neurological disorders

SIMPATHIC Consortium receives Horizon Grant from European Commission to revolutionise drug development

2023-04-17

(Press-News.org) The SIMPATHIC Consortium, led by the Radboud University Medical Center and Amsterdam UMC, has developed a new approach to expedite the use of existing drugs for groups of patients with rare neurological disorders. The consortium has been awarded an 8.8-million-euro grant from the Horizon Europe program to further develop this innovative method.

Traditionally, drugs are developed one disease at a time, which is costly and time-consuming. It often takes a long time before patients can use a new drug. The international SIMPATHIC Consortium, which comprises 22 international partners, has created a novel method for accelerating the use of existing drugs for other conditions, based on screening tissues from individual patients. The consortium's approach has been recognized and funded by the European Commission with an 8.8-million-euro grant.

The researchers will use a new technology to test the efficacy of existing drugs in patients with neurological disorders, requiring only a tube of blood or a small piece of skin from the patient. These materials contain stem cells that the researchers culture into nerve cells. They subsequently test how they respond to a variety of existing drugs.

If the researchers observe a positive effect of a drug, they will launch a clinical study in a group of patients with different disorders but similar clinical symptoms. As existing drugs have already been tested in humans, animal studies may not be necessary, which significantly accelerates the use of drugs in new applications and reduces research costs.

Project leader and bioinformatician Prof. Peter-Bram 't Hoen of Radboudumc explains, "The project will significantly improve the efficiency and speed of discovery, evaluation, and approval of new applications for existing drugs."

Project leader and pediatrician-biochemical geneticist Prof. Clara van Karnebeek of Amsterdam UMC adds: "In addition, it will have a huge impact on the care of patients with rare neurological disorders, for example, by accelerating drug availability for these debilitating conditions.

The SIMPATHIC Consortium comprises 22 partners, including research teams from Radboudumc, Amsterdam UMC, and other academic centres in Europe and Canada, European patient and patient training organizations, companies, and a European infrastructure network. The consortium's innovative approach is expected to revolutionise drug development.

END

ELSE PRESS RELEASES FROM THIS DATE:

Does depression affect the care and survival of patients with breast cancer?

2023-04-17

Study’s findings suggest that detecting and treating depression are critical to patient health. In a recent study, having depression before or after a breast cancer diagnosis was associated with a lower likelihood of survival. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. For the study, Bin Huang, DrPH, of the University of Kentucky Markey Cancer Center, and his colleagues analyzed data from the Kentucky Cancer Registry to identify adult women diagnosed with primary invasive breast cancer in 2007–2011. Utilizing the health claims–linked cancer registry data, the ...

Teen jobs: Some parents cautious about negative impact on grades, sleep and social life

2023-04-17

For many teens, that first formal job as a fast-food cashier, barista or lifeguard is a rite of passage. And while some families tout the positives of job experiences, such as improving their teen’s money management skills and self-esteem, others worry about the potential to negatively impact sleep, schedules and grades, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health. But finding a job that meets logistical considerations – with schedules and transportation topping the list ...

ARRS Annual Meeting: 4D flow MRI, 3D phantoms benefit atrial fibrillation patients

2023-04-17

Honolulu, HI | April 17, 2023—Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting at the Hawaiian Convention Center suggest that correctly occluded left atrial appendages (LAAs) could present maximal reduction in left atrial (LA) flow stasis and thrombogenicity, offering a clinical goal for the procedure in patients with atrial fibrillation. Pointing out the paucity of knowledge in atrial fibrillation (AF) populations regarding the actual flow dynamic changes before and after percutaneous left atrial appendage occlusion (LAAO), “we aimed to evaluate LA flow dynamics for pre-occluded, correctly occluded, and incorrectly ...

American Roentgen Ray Society (ARRS) Global Partners honor Jeong Min Lee, Korean Society of Radiology (KSR) President, with ARRS membership

2023-04-17

Honolulu, HI | April 17, 2023—The Global Partner Society Program of the American Roentgen Ray Society (ARRS) is proud to announce that Jeong Min Lee, President of the Korean Society of Radiology (KSR) and professor of radiology at South Korea’s Seoul National University Hospital, will receive Honorary Membership in ARRS during the opening ceremony of the 2023 ARRS Annual Meeting in Honolulu, HI. As per Section 6 of the ARRS bylaws, honorary members of the ARRS shall be those who have rendered valuable service ...

Over 1 million lives saved across Europe by COVID-19 vaccines since the end of 2020

2023-04-17

**Note: the release below is from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, 15-18 April). Please credit the conference if you use this story** COVID-19 vaccination directly saved at least 1,004,927 lives across Europe between December 2020 and March 2023, according to new research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15-18 April). The new estimates by WHO/Europe and presented at the conference by Dr Margaux Meslé, Epidemiologist at WHO/Europe highlight the striking ...

Long COVID incidence and severity no worse than post viral syndrome following seasonal influenza, study suggests

2023-04-17

**Note: the release below is from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, 15-18 April). Please credit the conference if you use this story** In the highly vaccinated population of Queensland exposed to the Omicron variant, long COVID appears to manifest as a post-viral syndrome of no greater incidence or severity than seasonal influenza, according to new research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15-18 April). The study by Queensland Health researchers suggests that despite the similarity of clinical outcomes ...

Metagenomic sequencing outperforms conventional tests to identify antimicrobial resistance in bloodstream infections

2023-04-17

Metagenomic sequencing can provide rapid and actionable antimicrobial resistance predictions to treat bloodstream infections much faster than conventional laboratory tests, and has the potential to save lives and better manage the use of antibiotics, according to new research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15-18 April). The study led by Dr Kumeren Govender from the John Radcliffe Hospital, University of Oxford, ...

Effect of COVID-19 pandemic on mortality in people with intellectual disabilities extended beyond deaths from COVID itself

2023-04-17

Mortality from COVID-19 in people with intellectual disabilities five times higher than general population Study showed death rates for cancers, mental health disorders, circulatory disorders, external causes, and other natural causes in people with intellectual disabilities were higher during the COVID pandemic than pre-pandemic Observed effects likely to be due a range of factors including disruptions to care during pandemic PLEASE NOTE Embargo: 0030H CEST Copenhagen time Monday 17 April *Note: ...

Connections in the brain involved in epileptic seizures identified

2023-04-17

Researchers at the UCL Queen Square Institute of Neurology have discovered a network of connections in the brain linked to seizures in people with epilepsy. The team believe that their findings, published in Brain, will help redesign neurological operations for patients whose epilepsy can’t be controlled by medication. By disconnecting certain pathways in the frontal lobe, patients may be able to enjoy long-lasting freedom from seizures. There are 500,000 people in the UK with epilepsy and 50 million people have the condition worldwide. But one in three cannot ...

New details of Tully monster revealed

2023-04-17

For more than half a century, the Tully monster (Tullimonstrum gregarium), an enigmatic animal that lived about 300 million years ago, has confounded paleontologists, with its strange anatomy making it difficult to classify. Recently, a group of researchers proposed a hypothesis that Tullimonstrum was a vertebrate similar to cyclostomes (jawless fish like lamprey and hagfish). If it was, then the Tully monster would potentially fill a gap in the evolutionary history of early vertebrates. Studies ...

8.8 million euros for accelerated drug repurposing for rare neurological disorders

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: